Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
Oncotargets and Therapy|August 21, 2018
Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based reviewEva M Donato, Miguel Fernández-Zarzoso, Jose Antonio Hueso, et al.
Chaos (Woodbury, N.Y.)|April 7, 2007
Patterns of spiral wave attenuation by low-frequency periodic planar frontsMiguel A de la Casa, F Javier de la Rubia, Plamen Ch Ivanov
Cancers|January 8, 2023
How to Manage Patients with Lenalidomide-Refractory Multiple MyelomaFelipe de Arriba de la Fuente, Carmen Montes Gaisán, Javier de la Rubia Comos
Physical Review. E|June 17, 2017
Synchronization of fluctuating delay-coupled chaotic networksManuel Jiménez-Martín, Javier Rodríguez-Laguna, Otti D'Huys, et al.
Expert Review of Hematology|February 14, 2024
Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and consInés Gómez Seguí, María Eva Mingot Castellano, Cristina Pascual Izquierdo, et al.
Expert Review of Hematology|December 20, 2022
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpuraInés Gómez-Seguí, Cristina Pascual Izquierdo, María Eva Mingot Castellano, et al.
Transfusion|August 5, 2005
Incidence of Wra antigen and anti-Wra in a Spanish populationFrancisco Arriaga, Francisco Llopis, Javier de la Rubia, et al.
Journal of Theoretical Biology|October 21, 1988
Influence of the hypercycle on the error threshold: a stochastic approachA García-Tejedor, J C Sanz-Nuño, J Olarrea, et al.
Transplantation and Cellular Therapy|July 7, 2023
Extracorporeal Photopheresis in Graft-versus-Host DiseasePedro Asensi Cantó, Jaime Sanz Caballer, Pilar Solves Alcaína, et al.
Pageof 20